PESUB26 The first-in-human clinical trial of STP0404, a novel potent HIV-1 allosteric integrase inhibitorPoster exhibitionPharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring
PESUC18 Disproportionate HIV burden among key populations in sub-Saharan Africa: national estimates of population size, HIV prevalence, and ART coveragePoster exhibitionSurveillance of HIV in key populations
PESUC19 Assessing levels of provincial HIV virological suppression in the public health sector in South Africa during the COVID-19 pandemicPoster exhibitionMonitoring and evaluation of health systems along the HIV cascade
PESUC20 Projection of age of people living with HIV and time since ART initiation in high-income countries in 2030: estimates for FrancePoster exhibitionModelling future healthcare needs
PESUC21 Life years gained with improved HIV care among non-Hispanic Black and White people who have ever injected drugs (PWID) with HIV: a modeling studyPoster exhibitionModelling the impact of service models on the HIV epidemic
PESUC22 Is Thailand on track to achieve 95-95-95 targets by 2025?Poster exhibitionModelling the impact of service models on the HIV epidemic
PESUC23 Characterising the HIV care cascade in Saskatoon, Saskatchewan, 2018 - 2021Poster exhibitionModelling the impact of service models on the HIV epidemic
PESUC24 Willingness to use PrEP among gay, bisexual, and other men who have sex with men in five Asian countries: results of the Asia Pacific MSM internet surveyPoster exhibitionDemand creation for PrEP use
PESUC25 Recovery in the uptake of pre-exposure prophylaxis (PrEP) in Australia after COVID-19 restrictions: analysis of national pharmacy dispensing dataPoster exhibitionScale up of PrEP
PESUC26 Fostering access to PrEP among high-risk adolescent girls and young women aged 16 to 24 years through the DREAMS initiative in 4 districts in ZambiaPoster exhibitionScale up of PrEP
2421 - 2430 of 2485 items